Literature DB >> 26378174

Genomic Analysis, Phenotype, and Virulence of the Historical Brazilian Smallpox Vaccine Strain IOC: Implications for the Origins and Evolutionary Relationships of Vaccinia Virus.

Maria Luiza G Medaglia1, Nissin Moussatché2, Andreas Nitsche3, Pjotr Wojtek Dabrowski3, Yu Li4, Inger K Damon4, Carolina G O Lucas5, Luciana B Arruda5, Clarissa R Damaso6.   

Abstract

UNLABELLED: Smallpox was declared eradicated in 1980 after an intensive vaccination program using different strains of vaccinia virus (VACV; Poxviridae). VACV strain IOC (VACV-IOC) was the seed strain of the smallpox vaccine manufactured by the major vaccine producer in Brazil during the smallpox eradication program. However, little is known about the biological and immunological features as well as the phylogenetic relationships of this first-generation vaccine. In this work, we present a comprehensive characterization of two clones of VACV-IOC. Both clones had low virulence in infected mice and induced a protective immune response against a lethal infection comparable to the response of the licensed vaccine ACAM2000 and the parental strain VACV-IOC. Full-genome sequencing revealed the presence of several fragmented virulence genes that probably are nonfunctional, e.g., F1L, B13R, C10L, K3L, and C3L. Most notably, phylogenetic inference supported by the structural analysis of the genome ends provides evidence of a novel, independent cluster in VACV phylogeny formed by VACV-IOC, the Brazilian field strains Cantagalo (CTGV) and Serro 2 viruses, and horsepox virus, a VACV-like virus supposedly related to an ancestor of the VACV lineage. Our data strongly support the hypothesis that CTGV-like viruses represent feral VACV that evolved in parallel with VACV-IOC after splitting from a most recent common ancestor, probably an ancient smallpox vaccine strain related to horsepox virus. Our data, together with an interesting historical investigation, revisit the origins of VACV and propose new evolutionary relationships between ancient and extant VACV strains, mainly horsepox virus, VACV-IOC/CTGV-like viruses, and Dryvax strain. IMPORTANCE: First-generation vaccines used to eradicate smallpox had rates of adverse effects that are not acceptable by current health care standards. Moreover, these vaccines are genetically heterogeneous and consist of a pool of quasispecies of VACV. Therefore, the search for new-generation smallpox vaccines that combine low pathogenicity, immune protection, and genetic homogeneity is extremely important. In addition, the phylogenetic relationships and origins of VACV strains are quite nebulous. We show the characterization of two clones of VACV-IOC, a unique smallpox vaccine strain that contributed to smallpox eradication in Brazil. The immunogenicity and reduced virulence make the IOC clones good options for alternative second-generation smallpox vaccines. More importantly, this study reveals the phylogenetic relationship between VACV-IOC, feral VACV established in nature, and the ancestor-like horsepox virus. Our data expand the discussion on the origins and evolutionary connections of VACV lineages.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26378174      PMCID: PMC4645304          DOI: 10.1128/JVI.01833-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  [Bovine variola (cowpox) in the state of São Paulo and its transmission to humans].

Authors:  L L VELLINI
Journal:  Hospital (Rio J)       Date:  1953-08

2.  Safety, immunogenicity and protective efficacy in mice of a new cell-cultured Lister smallpox vaccine candidate.

Authors:  Audrey Ferrier-Rembert; Robert Drillien; Bernard Meignier; Daniel Garin; Jean-Marc Crance
Journal:  Vaccine       Date:  2007-10-11       Impact factor: 3.641

Review 3.  The exit of vaccinia virus from infected cells.

Authors:  Geoffrey L Smith; Mansun Law
Journal:  Virus Res       Date:  2004-12       Impact factor: 3.303

4.  MAFFT multiple sequence alignment software version 7: improvements in performance and usability.

Authors:  Kazutaka Katoh; Daron M Standley
Journal:  Mol Biol Evol       Date:  2013-01-16       Impact factor: 16.240

5.  HIV-1 p55Gag encoded in the lysosome-associated membrane protein-1 as a DNA plasmid vaccine chimera is highly expressed, traffics to the major histocompatibility class II compartment, and elicits enhanced immune responses.

Authors:  Ernesto T A Marques; Priya Chikhlikar; Luciana Barros de Arruda; Ihid C Leao; Yang Lu; Justin Wong; Juei-Suei Chen; Barry Byrne; J Thomas August
Journal:  J Biol Chem       Date:  2003-06-24       Impact factor: 5.157

6.  Increased susceptibility of Cantagalo virus to the antiviral effect of ST-246®.

Authors:  Élida Santos-Fernandes; Cristiana O Beltrame; Chelsea M Byrd; Kara B Cardwell; Laila C Schnellrath; Maria Luiza G Medaglia; Dennis E Hruby; Robert Jordan; Clarissa R Damaso
Journal:  Antiviral Res       Date:  2012-12-17       Impact factor: 10.103

7.  Are we there yet? The smallpox research agenda using variola virus.

Authors:  Inger K Damon; Clarissa R Damaso; Grant McFadden
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

8.  Passatempo virus, a vaccinia virus strain, Brazil.

Authors:  Juliana A Leite; Betânia P Drumond; Giliane S Trindade; Zélia I P Lobato; Flávio G da Fonseca; Santos João R dos; Marieta C Madureira; Maria I M C Guedes; Jaqueline M S Ferreira; Cláudio A Bonjardim; Paulo C P Ferreira; Erna G Kroon
Journal:  Emerg Infect Dis       Date:  2005-12       Impact factor: 6.883

9.  A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus.

Authors:  Nicholas E Peters; Brian J Ferguson; Michela Mazzon; Aodhnait S Fahy; Ewelina Krysztofinska; Raquel Arribas-Bosacoma; Laurence H Pearl; Hongwei Ren; Geoffrey L Smith
Journal:  PLoS Pathog       Date:  2013-10-03       Impact factor: 6.823

10.  Cellular and humoral immunity against vaccinia virus infection of mice.

Authors:  Rong Xu; Aaron J Johnson; Denny Liggitt; Michael J Bevan
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

View more
  17 in total

1.  Serro 2 Virus Highlights the Fundamental Genomic and Biological Features of a Natural Vaccinia Virus Infecting Humans.

Authors:  Giliane de Souza Trindade; Ginny L Emerson; Scott Sammons; Michael Frace; Dhwani Govil; Bruno Eduardo Fernandes Mota; Jônatas Santos Abrahão; Felipe Lopes de Assis; Melissa Olsen-Rasmussen; Cynthia S Goldsmith; Yu Li; Darin Carroll; Flavio Guimarães da Fonseca; Erna Kroon; Inger K Damon
Journal:  Viruses       Date:  2016-12-10       Impact factor: 5.048

Review 2.  Vaccinia Virus Natural Infections in Brazil: The Good, the Bad, and the Ugly.

Authors:  Jaqueline Silva de Oliveira; Poliana de Oliveira Figueiredo; Galileu Barbosa Costa; Felipe Lopes de Assis; Betânia Paiva Drumond; Flávio Guimarães da Fonseca; Maurício Lacerda Nogueira; Erna Geessien Kroon; Giliane de Souza Trindade
Journal:  Viruses       Date:  2017-11-15       Impact factor: 5.048

3.  Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments.

Authors:  Ryan S Noyce; Seth Lederman; David H Evans
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

4.  A Critical Analysis of the Scientific and Commercial Rationales for the De Novo Synthesis of Horsepox Virus.

Authors:  Gregory D Koblentz
Journal:  mSphere       Date:  2018-03-07       Impact factor: 4.389

Review 5.  Bovine Vaccinia: Insights into the Disease in Cattle.

Authors:  Ana Carolina Diniz Matos; Izabelle Silva Rehfeld; Maria Isabel Maldonado Coelho Guedes; Zélia Inês Portela Lobato
Journal:  Viruses       Date:  2018-03-09       Impact factor: 5.048

6.  The origins and genomic diversity of American Civil War Era smallpox vaccine strains.

Authors:  Ana T Duggan; Jennifer Klunk; Ashleigh F Porter; Anna N Dhody; Robert Hicks; Geoffrey L Smith; Margaret Humphreys; Andrea M McCollum; Whitni B Davidson; Kimberly Wilkins; Yu Li; Amanda Burke; Hanna Polasky; Lowell Flanders; Debi Poinar; Amogelang R Raphenya; Tammy T Y Lau; Brian Alcock; Andrew G McArthur; G Brian Golding; Edward C Holmes; Hendrik N Poinar
Journal:  Genome Biol       Date:  2020-07-20       Impact factor: 13.583

7.  Genome Sequence of Vaccinia virus Strain Lister-Butantan, a Lister Vaccine Variant Used during a Smallpox Eradication Campaign in Brazil.

Authors:  Felipe Assis; Giliane Trindade; Betânia Drumond; Mike Frace; Scott Sammons; Ginny Emerson; Yu Li; Darin Carroll; Dhwani Batra; Jonatas Abrahão; Erna Kroon
Journal:  Genome Announc       Date:  2016-06-23

8.  Dairy production practices and associated risks for bovine vaccinia exposure in cattle, Brazil.

Authors:  I A Borges; A M McCollum; J M Mehal; D Haberling; L A L Dutra; F N Vieira; L A O Andrade; E G Kroon; R C Holman; M G Reynolds; G S Trindade
Journal:  New Microbes New Infect       Date:  2017-08-16

9.  Synthetic viruses-Anything new?

Authors:  Volker Thiel
Journal:  PLoS Pathog       Date:  2018-10-04       Impact factor: 6.823

10.  Beyond the myths: Novel findings for old paradigms in the history of the smallpox vaccine.

Authors:  José Esparza; Andreas Nitsche; Clarissa R Damaso
Journal:  PLoS Pathog       Date:  2018-07-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.